Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

0
Player Avatar solanZRaider (< 20) Submitted: 4/26/2011 3:19:12 PM : Outperform Start Price: $3.06 ARRY Score: +15.07

Momentum21 & usubanas

Featured Broker Partners


Advertisement